股东通过反向股分重组方案，解决低股价并维持上市。

summarizeSummary

Healthcare Triangle, Inc. shareholders have approved a reverse stock split, a critical step for the company currently trading near its 52-week low of $0.1558. This approval, following preliminary and definitive proxy statements filed on January 9 and January 20, 2026, respectively, grants the Board of Directors the authority to implement a reverse split at a ratio between 1-for-2 and 1-for-100. This action is typically undertaken by companies to increase their per-share price, often to meet minimum bid price requirements for continued listing on exchanges like Nasdaq, thereby preventing potential delisting. The Board's discretion in setting the final ratio allows flexibility in achieving the desired share price. Investors should monitor the Board's decision on the specific ratio and the effective date of the split, as it will significantly impact the number of outstanding shares and the per-share price.

check_boxKey Events

• 特别股东会议召开

  医疗保健三角形公司于2026年2月2日在线举行了2026年特别股东大会，出席股东所持有股权的近66.35%。

• 已获得股价反向合并的批准

  Shareholders approved an amendment to the company's Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1-for-2 to 1-for-100, with the exact ratio to be determined by the Board of Directors.

• 会议休会提议获得通过

  股东们还批准了如果需要的话，将特别会议延迟至为征求更多的投票权而进行的议案。

auto_awesomeAnalysis

医疗集团公司（Healthcare Triangle, Inc.）股东已批准实施反向股分（reverse stock split），这是公司当前股价接近其52周最低点（$0.1558）的关键一步。批准此项措施后，董事会将具有实施反向股分的权力，分配比率为1：2至1：100。公司通常会采取此类行动，以提高每股价格，满足纳斯达克（Nasdaq）等交易所的最低收盘价要求，避免潜在的退市。董事会在确定最终分配比率时具有自主权，这使得他们能够灵活地实现所需的股价。投资者应密切关注董事会关于具体分配比率和实施日期的决定，因为这将显著影响发行的股票数量和每股价格。